Cargando…
Clinical Efficacy of Levosimendan vs Milrinone in Preventing Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
BACKGROUND: Prophylactic milrinone is commonly used to prevent Low Cardiac Output Syndrome (LCOS) after pediatric cardiac surgery. This study compares the use of levosimendan with milrinone when used as the primary inotrope following pediatric cardiac surgery. SUBJECTS AND METHODS: Forty infants und...
Autores principales: | Jothinath, Kaushik, Balakrishnan, Soundaravalli, Raju, Vijayakumar, Menon, Shoba, Osborn, Jenit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253017/ https://www.ncbi.nlm.nih.gov/pubmed/33884979 http://dx.doi.org/10.4103/aca.ACA_160_19 |
Ejemplares similares
-
One-Year Experience after Adoption of an On-Table Extubation Protocol Following Pediatric Cardiac Surgery
por: Kaushik, Jothinath, et al.
Publicado: (2022) -
Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
por: Milwidsky, Assi, et al.
Publicado: (2022) -
Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021) -
Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
por: Guerrero Orriach, Jose Luis, et al.
Publicado: (2019) -
Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts
por: Matsumoto, Shuhei, et al.
Publicado: (2012)